NMDA receptor regulation of nNOS phosphorylation and induction of neuron death

Neurobiology of Aging

Volumn 24, Issue 8, 2003, Pages 1123-1133

  Rameau, Gerald A ^a   Chiu, Ling Yu ^a   Ziff, Edward B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcineurin; Excitotoxic death; Kinase; Neuronal nitric oxide synthase; Nitrotyrosine; NMDA receptor; Phosphatase; TUNEL

Indexed keywords

3 BROMO 7 NITROINDAZOLE; 3 NITROTYROSINE; 3-NITROTYROSINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM ION; CYCLOSPORIN A; DIZOCILPINE; DRUG DERIVATIVE; ENZYME INHIBITOR; FLUORESCEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEURAL CONSTITUTIVE NITRIC OXIDE SYNTHASE; NIFEDIPINE; NITRIC OXIDE SYNTHASE; OKADAIC ACID; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; TACROLIMUS; TETRODOTOXIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; BRAIN NERVE CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYMOLOGY; METABOLISM; MICROSCOPY; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

EID: 0345276559     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.07.002     Document Type: Conference Paper

References (49)

1. Almeida A., Bolanos J.P. A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J. Neurochem. 77:2001;676-690.
2. Ayata C., Ayata G., Hara H., Matthews R.T., Beal M.F., Ferrante R.J.et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J. Neurosci. 17:1997;6908-6917.
3. Blitzer R.D., Connor J.H., Brown G.P., Wong T., Shenolikar S., Iyengar R.et al. Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science. 280:1998;1940-1942.
4. Bochelen D., Rudin M., Sauter A. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J. Pharmacol. Exp. Ther. 288:1999;653-659.
5. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7162-7166.
6. Bredt D.S., Ferris C.D., Snyder S.H. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267:1992;10976-10981.
7. Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9030-9033.
8. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
9. Brenman J.E., Bredt D.S. Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7:1997;374-378.
10. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
11. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274:1999;27467-27473.
12. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W.et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158:2002;507-517.
13. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11:2001;327-335.
14. Dalkara T., Yoshida T., Irikura K., Moskowitz M.A. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 33:1994;1447-1452.
15. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7797-7801.
16. Dawson T.M., Dawson V.L., Snyder S.H. Nitric oxide as a mediator of neurotoxicity. NIDA Res. Monogr. 136:1993;258-271.
17. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9808-9812.
18. Dawson V.L. Potent neuroprotectants linked to bifunctional inhibition. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10557-10558.
19. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
20. Eliasson M.J., Huang Z., Ferrante R.J., Sasamata M., Molliver M.E., Snyder S.H.et al. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19:1999;5910-5918.
21. Esplugues J.V. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 135:2002;1079-1095.
22. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P. Jr., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
23. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I.et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989.
24. Gonzalez-Zulueta M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W.et al. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18:1998;2040-2055.
25. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T.et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1996;1017-1021.
26. Hayashi Y., Nishio M., Naito Y., Yokokura H., Nimura Y., Hidaka H.et al. Regulation of neuronal nitric-oxide synthase by calmodulin kinases. J. Biol. Chem. 274:1999;20597-20602.
27. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
28. Hyman B.T., Marzloff K., Wenniger J.J., Dawson T.M., Bredt D.S., Snyder S.H. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:1992;818-820.
29. Isaac J. Protein phosphatase 1 and LTD: synapses are the architects of depression. Neuron. 32:2001;963-966.
30. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356:1998;1-11.
31. Keller J.N., Kindy M.S., Holtsberg F.W., St. Clair D.K., Yen H.C., Germeyer A.et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
32. Komeima K., Hayashi Y., Naito Y., Watanabe Y. Inhibition of neuronal nitric-oxide synthase by calcium/calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG108-15 neuronal cells. J. Biol. Chem. 275:2000;28139-28143.
33. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
34. Manabe Y., Wang J.M., Murakami T., Warita H., Hayashi T., Shoji M.et al. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite. J. Neurosci. Res. 65:2001;371-377.
35. Mihm M.J., Schanbacher B.L., Wallace B.L., Wallace L.J., Uretsky N.J., Bauer J.A. Free 3-nitrotyrosine causes striatal neurodegeneration in vivo. J. Neurosci. 21:2001;RC149.
36. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
37. Nakane M., Mitchell J., Forstermann U., Murad F. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem. Biophys. Res. Commun. 180:1991;1396-1402.
38. Panda K., Ghosh S., Stuehr D.J. Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J. Biol. Chem. 276:2001;23349-23356.
39. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaw S. et al. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3059-3064.
40. Rameau G.A., Akaneya Y., Chiu L., Ziff E.B. Role of NMDA receptor functional domains in excitatory cell death. Neuropharmacology. 39:2000;2255-2266.
41. Regan R.F., Choi D.W. The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res. 633:1994;236-242.
42. Rossig L., Fichtlscherer B., Breitschopf K., Haendeler J., Zeiher A.M., Mulsch A.et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J. Biol. Chem. 274:1999;6823-6826.
43. Ruiz F., Alvarez G., Ramos M., Hernandez M., Bogonez E., Satrustegui J. Cyclosporin A targets involved in protection against glutamate excitotoxicity. Eur. J. Pharmacol. 404:2000;29-39.
44. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 284:1999;1845-1848.
45. + channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neurosci. 16:1996;5004-5013.
46. Ward M.W., Rego A.C., Frenguelli B.G., Nicholls D.G. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurosci. 20:2000;7208-7219.
47. White R.J., Reynolds I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16:1996;5688-5697.
48. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J.et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:2002;259-263.
49. Zech B., Kohl R., Von Knethen A., Brune B. Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem. J. 371:2003;1055-1064.